385 related articles for article (PubMed ID: 21126615)
21. Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease.
Faergeman O; Holme I; Fayyad R; Bhatia S; Grundy SM; Kastelein JJ; LaRosa JC; Larsen ML; Lindahl C; Olsson AG; Tikkanen MJ; Waters DD; Pedersen TR;
Am J Cardiol; 2009 Aug; 104(4):459-63. PubMed ID: 19660594
[TBL] [Abstract][Full Text] [Related]
22. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
[TBL] [Abstract][Full Text] [Related]
23. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
[TBL] [Abstract][Full Text] [Related]
24. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
[TBL] [Abstract][Full Text] [Related]
25. Determinants of blood uric acid levels in a dyslipidemic Arab population.
Al-Meshaweh AF; Jafar Y; Asem M; Akanji AO
Med Princ Pract; 2012; 21(3):209-16. PubMed ID: 22095038
[TBL] [Abstract][Full Text] [Related]
26. The relationship between serum uric acid concentration and metabolic syndrome in university freshmen.
Lin KP
J Nurs Res; 2009 Dec; 17(4):286-92. PubMed ID: 19955885
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country.
Conen D; Wietlisbach V; Bovet P; Shamlaye C; Riesen W; Paccaud F; Burnier M
BMC Public Health; 2004 Mar; 4():9. PubMed ID: 15043756
[TBL] [Abstract][Full Text] [Related]
28. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
[TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome is associated with severe coronary artery disease and poor cardiac outcome in end-stage renal disease patients with acute coronary syndrome.
Chen HH; Wu CJ; Chen YC; Tsai CS; Lin FJ; Yeh HI
Coron Artery Dis; 2006 Nov; 17(7):593-6. PubMed ID: 17047442
[TBL] [Abstract][Full Text] [Related]
30. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
[TBL] [Abstract][Full Text] [Related]
31. Relation of body mass index to mortality among men with coronary heart disease.
Benderly M; Boyko V; Goldbourt U
Am J Cardiol; 2010 Aug; 106(3):297-304. PubMed ID: 20643236
[TBL] [Abstract][Full Text] [Related]
32. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction.
Zeller M; Steg PG; Ravisy J; Laurent Y; Janin-Manificat L; L'Huillier I; Beer JC; Oudot A; Rioufol G; Makki H; Farnier M; Rochette L; Vergès B; Cottin Y;
Arch Intern Med; 2005 May; 165(10):1192-8. PubMed ID: 15911735
[TBL] [Abstract][Full Text] [Related]
34. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
[TBL] [Abstract][Full Text] [Related]
35. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
[TBL] [Abstract][Full Text] [Related]
36. Association of the metabolic syndrome with early coronary disease in families with frequent myocardial infarction.
Reinhard W; Holmer SR; Fischer M; Gloeckner C; Hubauer U; Baessler A; Mayer B; Schunkert H; Riegger GA; Hengstenberg C
Am J Cardiol; 2006 Apr; 97(7):964-7. PubMed ID: 16563895
[TBL] [Abstract][Full Text] [Related]
37. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
[TBL] [Abstract][Full Text] [Related]
38. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
[TBL] [Abstract][Full Text] [Related]
39. Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
Bozbaş H; Yildirir A; Pirat B; Eroğlu S; Korkmaz ME; Atar I; Ulus T; Aydinalp A; Ozin B; Müderrisoğlu H
Anadolu Kardiyol Derg; 2008 Apr; 8(2):111-5. PubMed ID: 18400630
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
Suadicani P; Hein HO; Gyntelberg F
Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
